Response to COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Gender Equality Strategy 2026-2030

11 Aug 2025

Meeting with Stéphane Séjourné (Executive Vice-President) and 5 other attendees

19 May 2025 · Compétitivité, Simplification

Meeting with Pascal Arimont (Member of the European Parliament) and RPP Group

25 Mar 2025 · Addressing the Needs of Individuals with Geographic Atrophy (GA) and Vision Impairment – Breakfast discussion

Meeting with Stéphane Séjourné (Executive Vice-President) and 9 other attendees

21 Mar 2025 · - Marché intérieur - Compétitivité - Sécurité économique - Simplification - Relation USA / Europe

Meeting with Pascal Arimont (Member of the European Parliament) and RPP Group

25 Feb 2025 · Geographic Atrophy

Meeting with Pascal Arimont (Member of the European Parliament)

16 Jan 2025 · Geographic Atrophy

Meeting with Pascal Arimont (Member of the European Parliament)

11 Dec 2024 · Geographic Atrophy

Meeting with Elena Nevado Del Campo (Member of the European Parliament)

4 Dec 2024 · Plan de Acción Europeo en Trasplantes

Meeting with Pascal Arimont (Member of the European Parliament)

4 Nov 2024 · Geographic Atrophy and EU Activity

Meeting with Pascal Arimont (Member of the European Parliament)

9 Sept 2024 · Growing burden of geographic

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

25 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and 5 other interest representatives

23 Jan 2024 · Pharmaceutical Package (Regulation)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 8 other interest representatives

12 Dec 2023 · Directive on Medicinal products for human use

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 11 other interest representatives

18 Jul 2023 · Directive on Medicinal products for human use

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

18 Feb 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

26 Apr 2021

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020